Entera Bio Ltd.
ENTX
$2.89
$0.020.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -60.66% | -22.65% | -19.89% | -17.47% | -24.20% |
| Total Depreciation and Amortization | -16.22% | -29.27% | -34.78% | -29.17% | -27.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 120.39% | 5.54% | 8.46% | 12.90% | 48.43% |
| Change in Net Operating Assets | -78.03% | -55.92% | 1,022.32% | 197.40% | 297.65% |
| Cash from Operations | -63.60% | -42.39% | -8.10% | 12.10% | 9.31% |
| Capital Expenditure | -82.50% | -800.00% | -3,466.67% | -1,560.00% | -700.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -82.50% | -800.00% | -3,466.67% | -1,560.00% | -700.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -37.45% | -96.83% | 191.14% | 119.53% | 116.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 69.56% | 85.07% | 18.89% | 5.51% | 5.68% |
| Cash from Financing | -36.35% | -97.17% | 206.30% | 129.81% | 126.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.99% | -175.46% | 367.33% | 1,519.47% | 14,756.72% |